SMAD2 and neuroblastoma: Consistently, we demonstrated that the treatment of NB cells with rTGF-β1 (1500 pg/ml for 72 h) increased the phosphorylation of NF-κB p65 and SMAD2 over time for at least 24 h (Fig. 2d).